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Abstract. Cross-sectional studies report notable discrepancies between patient and caregiver ratings of the quality of life of
patients (QoL-p) with Alzheimer’s disease (AD). This study aimed to identify the factors associated with any changes in
QoL-p ratings and any discrepancies between patient and caregiver ratings of QoL-p. Three-year follow-up of a cohort of non-
institutionalized patients (n = 119). QoL-p was assessed by the Quality of Life in AD (QoL-AD) scale. We analyzed the influence
of functional and cognitive status and behavioral problems in patients, and burden and mental health in caregivers. Repeated
measures analysis was applied to the scores of patients and caregivers on the QoL-AD, and to the discrepancies between them.
Generally, patients’ own ratings remained stable over time (F3,116 = 0.9, p = 0.439), whereas caregiver ratings showed a decline
(F3,116 = 9.4, p < 0.001). In the analysis of discrepancies, patients with anosognosia gave higher ratings (F1,117 = 11.9, p = 0.001),
whereas caregiver ratings were lower when the patient showed greater agitation (F1,117 = 13.0, p < 0.001), apathy (F1,117 = 15.4,
p < 0.001), and disabilities (F1,117 = 17.1, p < 0.001), and when the caregiver experienced greater burden (F1,117 = 9.0, p = 0.003)
and worse mental health (F1,117 = 10.1, p = 0.003). Patient ratings of QoL-p remain generally stable over time, whereas those of
caregivers show a decline, there being significant discrepancies in relation to specific patient and caregiver factors.
Keywords: Alzheimer’s disease, anosognosia, caregiver burden, caregivers, disabilities, longitudinal study, mental health, neu-
ropsychiatric symptoms, patients, quality of life
INTRODUCTION
Quality of life is an important concern for peo-
ple with Alzheimer’s disease (AD). Although their
caregivers may share these concerns, they are also con-
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cerned with other more therapeutic issues, such as the
medication and treatment that are available [1]. Evalu-
ating the ability of therapeutic interventions to improve
the quality of life of patients (QoL-p) with AD is now
recognized as an important issue [2–5].
However, certain aspects of the factors that influence
perceived QoL-p in patients and caregivers require
further clarification, especially as regards the role
of depression, anosognosia, and disease severity in
ISSN 1387-2877/14/$27.50 © 2014 – IOS Press and the authors. All rights reserved
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patients, and mental health and burden in caregivers.
Cross-sectional studies have found notable discrepan-
cies between patient and caregiver ratings of QoL-p,
and these discrepancies have been shown to increase
as the dementia becomes more severe, as well as in the
presence of anosognosia [6]. This raises doubts about
the validity of ratings made in relation to patients with
advanced dementia [7]. Burden and depression in the
caregiver may also affect their ratings of QoL-p [8, 9].
Given that we are dealing with what are essentially sub-
jective perceptions, it is important to understand which
factors may be most closely associated with differ-
ences in patient and caregiver ratings, especially since
quality of life is one of the aspects considered when
evaluating the suitability and effectiveness of clinical
interventions. In this regard, it is also important to know
whether caregiver reports offer a valid account of the
patient’s subjective experience.
Few longitudinal studies have yet to be carried out
in this area, although they could help to clarify these
discrepancies and the factors associated with them.
Research involving a follow-up of more than one year
has produced a consistent finding in relation to one
general aspect: patient ratings of QoL-p do not change
substantially during follow-up [8, 10–12], whereas
caregiver ratings become significantly worse [10,11,
13, 14]. However, although the patient’s own view does
not change substantially during follow-up some studies
have found that functional deficits and global impair-
ment are related to poorer patient ratings of QoL-p,
while better cognitive functioning is associated with
higher ratings [12]. In another study, depression and
anxiety, but not the level of cognitive functioning, were
associated with a decline in ratings [8].
In terms of caregiver perceptions of QoL-p, their
ratings have been found to decline as a function of cer-
tain patient factors: functional loss in activities of daily
living [11, 14], increased neuropsychiatric symptoms
[10, 11], a lower level of cognitive functioning [10,
14], greater depression [14], and when the caregiver’s
baseline rating was already lower [13].
However, studies with more than one year of
follow-up have yet to examine the changes in and dis-
crepancies between the ratings of both patients and
caregivers. The present longitudinal study involved a
three-year follow-up and analyzed, in both patients and
caregivers, the changes in QoL-p ratings, the factors
associated with these ratings, and any discrepancies
between the two groups. The specific aims of the study
were as follows: 1) to determine changes over time
in patient and caregiver ratings of QoL-p; 2) to iden-
tify the factors associated with any changes in QoL-p
ratings; and 3) to identify any discrepancies between
patient and caregiver ratings of QoL-p.
MATERIAL AND METHODS
Design and study population
This was a prospective cohort study of non-
institutionalized patients with AD and their family
caregivers over a period of three years.
All the patients were diagnosed with either AD
according to DSM-IV (Diagnostic and Statistical Man-
ual of Mental Disorders) criteria [15] or probable
AD according to NINCDS-ADRDA (National Insti-
tute of Neurological and Communicative Disorders
and Stroke/Alzheimer’s Disease and Related Disorders
Associations) [16]. The sample also comprised their
respective family caregivers, defined as the person with
main responsibility for helping the patient with activ-
ities of daily living (ADLs). Patients were excluded if
they presented vascular or traumatic events, alcohol or
substance dependency or abuse, and if they had severe
communication problems that prevented them from
responding adequately to the assessment questions.
All the AD subjects were seen as out-patients in the
Memory and Dementia Assessment Unit of the Santa
Caterina Hospital in Girona (Spain) and formed part of
the SIDEA research project (Seguimiento Integral de la
Enfermedad de Alzheimer––Comprehensive Follow-
Up of Alzheimer’s Disease). This project is an observa-
tional, longitudinal, and pragmatic cohort study. Using
a standardized protocol, it aims to describe and follow-
up a large cohort of patients diagnosed with AD, as
well as their family caregivers, who receive outpa-
tient medical and social care at secondary-level centers
in our area. As part of this project the present study
was approved by the Ethics Committee for Clinical
Research of the local health authority.
The data corresponding to the baseline assessment
of this study have been previously published [17].
Sample power
The sample comprised 119 patients and their respec-
tive family caregivers. This sample size was sufficient
to detect (with a power of 88.9% and 99.9% in the base-
line and final assessments, respectively, and accepting
an alpha risk of 0.05 and a beta risk of 0.20 in a
two-tailed independent contrast) a difference between
patients and caregivers of 2.8 points in the baseline
QoL-AD score (standard deviation [SD] = 4.8) and 4.6
points in the final QoL-AD score (SD = 6.0).
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Instruments
Measuring quality of life
The Quality of Life in Alzheimer’s Disease (QoL-
AD) scale was administered to patients and caregivers
in order to assess their perception of QoL-p. The scale
consists of thirteen items that reflect the subject’s
perception of different aspects related to wellbeing:
physical health, energy, mood, living situation, mem-
ory, family, marriage, friends, self as a whole, ability
to do chores around the house, ability to do things for
fun, money, and life as a whole. Possible scores range
from 13–52 [18], with higher scores indicating better
perceived QoL.
Socio-demographic data
The socio-demographic characteristics of the patient
and caregiver (age, gender, marital status, level of
education, place of residence, family relationship,
and whether they lived together) were recorded by
means of a structured interview, the Cambridge Men-
tal Disorders of the Elderly Examination (CAMDEX)
[19].
Clinical data of patients
The clinical examination of the patient was con-
ducted using the following instruments:
Cambridge Mental Disorders of the Elderly Exam-
ination (CAMDEX). The items used were those
corresponding to the intensity of depressive symptoms
(absent, mild, and moderate), the severity of demen-
tia (mild and moderate), and anosognosia (present or
absent). Data for these three variables correspond to
the clinical observation of the examiner. The cognitive
part of the CAMDEX, the Cambridge Cognitive Exam-
ination (CAMCOG) [19], was also applied. Possible
scores range from 0–107, with higher scores indicating
better cognitive function.
MiniMental StateExamination (MMSE).This is a brief
cognitive examination whose scores range from 0 to
30 [20]; the higher the score, the better the cognitive
function.
Disability Assessment for Dementia (DAD). This scale
was administered to caregivers and assesses a wide
range of daily living activities (ADL): basic, instru-
mental, and leisure. It comprises 40 items and scores
range from 0–80 [21]. Higher scores are indicative of
better functional status.
Neuropsychiatric Inventory (NPI). This instrument
for evaluating psychiatric symptomatology in AD is
administered to the caregiver. It comprises twelve sub-
scales and score ranges from 0–144 [22]. The higher
the score, the more symptoms are presented by the
patient.
Clinical data of caregivers
The clinical examination of the caregiver was con-
ducted using the following instruments:
SF-12 Health Survey (SF-12v1). Short form of the
SF-36 Health Survey. Two global dimensions can be
obtained from the direct scores: physical health and
mental health, and in both dimensions the score ranges
from 0–100 [23]. The higher the score, the better the
respondent’s health.
Zarit Burden Interview (ZBI). This questionnaire was
designed to assess the burden experienced by care-
givers and it comprises 22 items that are scored on
a Likert scale ranging from 1 (never) to 5 (almost
always). The total score therefore ranges between 22
and 110, and higher scores indicate greater burden
[24].
Procedure
In the initial interview, the aims of the study were
explained to patients and caregivers, who were then
interviewed separately. All the patients and their care-
givers gave their written consent to participate in the
study. The assessment instruments were administered
by a clinical neuropsychology research team from the
hospital.
The baseline assessment interviews were conducted
between July 2003 and July 2009. Participants in the
present study were followed up at 12, 24, and 36
months after baseline.
Statistical analysis
A descriptive analysis was carried out of the clinical
and socio-demographic characteristics of the sample,
using absolute and relative frequencies for qualitative
variables and measures of central trend and dispersion
for quantitative variables. The influence of clinical and
socio-demographic variables on the QoL-AD scores of
patients and caregivers, and any discrepancy between
these scores, was analyzed by means of parametric
tests (analysis of variance [F] and the Student’s t test
[t] or non-parametric tests (Mann-Whitney U [z] and
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Spearman [rs ] correlations), in accordance with criteria
of normality. Pearson’s χ2 test was used for categori-
cal variables. When there was a significant difference
between two measures, Cohen’s (d) was calculated to
determine the effect size.
In a first step we compared the clinical and socio-
demographic data of the sample analyzed with the
corresponding data for cases lost to follow-up. A
repeated measures analysis of variance (within sub-
jects) was then used to determine any changes over
time in perceived QoL-p and for each of the patient and
caregiver factors. When the sphericity assumption was
not fulfilled (Mauchly’s test), a multivariate approach
was used. The repeated measures analyses included
119 patients and their respective caregivers, who were
assessed at four time points.
In order to determine the factors associated with
variation in QoL-p ratings, several regression analyses
were performed, taking as the dependent variables the
scores on the QoL-AD at baseline and at 36 months, as
well as the differences between these two scores. These
regression analyses used the Enter method (introduc-
ing all the variables in a single step). In the multiple
linear regression analysis, the coefficient of contribu-
tion for each variable was calculated by means of the
solution suggested by Guilford and Fruchter [25]: beta
coefficient × the coefficient of correlation with the
dependent variable.
The degree of agreement between patient and
caregiver responses to the 13 QoL-AD items was deter-
mined by calculating weighted and unweighted kappa
(k) indices; the weights used were 1.0/0.7/0.3/0.0,
depending on the degree of agreement between the four
categories of each item.
The factors associated with discrepancies between
patient and caregiver ratings of QoL-p were identi-
fied by means of repeated measures (between-subjects)
ANOVA, the dependent variable being discrepan-
cies between patient and caregiver ratings of QoL-p
at the four assessment points. The between-subjects
variables were the dichotomized clinical and socio-
demographic factors.
The values for partial eta-squared (η2p ) were inter-
preted as indicating small effects (0.01–0.05), medium
effects (0.058–0.13), or large effects (≥0.14) (Cohen,
1973 [26]). The η2p statistic indicates the percentage of
variability in the dependent variable that is explained
by a given factor (range 0–1). Effect sizes for dif-
ferences between means (d) were defined as small
(0.2–0.4), medium (0.5–0.8), or large (>0.8) [27].
For hypothesis contrasts, the level of statistical sig-
nificance was set at 0.05. All data processing and
analysis was performed using SPSS 17.0 for Windows
(SPSS Inc.; Chicago).
RESULTS
Description of the sample
The initial cohort included 337 participants, but of
these, 218 cases were lost to follow-up, primarily due
to deterioration in the patient (43%), exitus (15%),
change of address (7%), or for unknown reasons (35%).
The study sample therefore comprised 119 patients and
their respective caregivers, all of whom completed the
assessment at baseline and at 12, 24, and 36 months.
The comparison of study participants with those lost to
follow-up is shown in Table 1. At baseline, patients lost
to follow-up were older, had greater cognitive impair-
ment, lower functional status, more neuropsychiatric
symptoms, and greater overall impairment. There were
no significant differences between the two sets of care-
givers.
Clinical data of participants
The global data for patients revealed a progressive
deterioration over the three years of follow-up, espe-
cially as regards their cognitive functioning (MMSE
and CAMCOG) and functional status (DAD). The
results from the CAMDEX showed an increase in the
severity of dementia, as well as in anosognosia. With
respect to neuropsychiatric symptoms, there were no
significant differences in the global score, but three
of the subscales did show an increase over time:
NPI-Anxiety (F3,116 = 4.3, p = 0.006; η2p = 0.10), NPI-
Apathy (F3,116 = 3.9, p = 0.010; η2p = 0.09), and
NPI-Aberrant motor behavior (F3,116 = 3.0, p = 0.030;
η2p = 0.07). Among caregivers, the only variable that
showed a progressive and significant increase over time
was burden (ZBI) (see Table 2).
Patients’ own ratings of QoL-p did not differ signif-
icantly across the four assessment points (F3,116 = 0.9,
p = 0.439; η2p = 0.02). By contrast, caregiver ratings
showed a general decline (F3,116 = 9.4, p < 0.001;
η2p = 0.19). The overall discrepancy between patient
and caregiver ratings increased over the 36 months
of follow-up (F3,116 = 6.4, p < 0.001; η2p = 0.14), and
especially after 12 months, coinciding with more
severe dementia (baseline differences: t118 = 6.3, p <
0.001, η2p = 0.25; at 12 months: t118 = 5.4, p < 0.001,
η2p = 0.20; at 24 months: t118 = 6.6, p < 0.001, η2p =
0.27; at 36 months: t118 = 8.3, p < 0.001, η2p = 0.36).
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Table 1
Comparison (at baseline) of the two groups
Study participants Lost to follow-up Differences
(n = 119) (n = 218) Test (df) p d
Patient factors
Age (years) 77.0 ± 6.7 78.6 ± 6.8 2.46a 0.014 0.23
Women (%) 76 (63.9) 144 (66.1) 0.16 (1)b 0.687
Education,≥6 years (%) 72 (60.5) 124 (56.9) 0.41 (1)b 0.519
MMSE (cognition) 18.9 ± 3.6 17.3 ± 4.5 3.00a 0.003 0.39
CAMCOG (cognition) 58.9 ± 9.9 52.9 ± 12.7 4.31a <0.001 0.52
DAD (ADL) 68.7 ± 7.8 65.5 ± 8.6 3.34a 0.001 0.38
NPI (behavioral) 9.4 ± 9.4 12.4 ± 13.3 1.99a 0.047 0.26
CAMDEX (%)
Depression, mild-moderate 17 (14.3) 40 (18.3) 1.39 (2)b 0.498
Dementia, moderate 12 (10.1) 42 (19.3) 7.78 (2)b 0.020
Anosognosia 11 (9.2) 22 (10.1) 0.06 (1)b 0.802
Caregiver factors
Age (years) 61.0 ± 14.6 58.8 ± 14.2 1.42a 0.155
Women (%) 82 (68.9) 150 (68.8) 0.00 (1)b 0.985
Education,≥6 years (%) 94 (79.0) 175 (80.3) 0.07 (1)b 0.779
ZBI (burden) 39.7 ± 12.5 41.9 ± 12.8 1.74a 0.082
SF-12 (physical health) 49.9 ± 9.2 50.2 ± 8.9 0.14a 0.888
SF-12 (mental health) 46.7 ± 11.0 45.7 ± 11.2 0.78a 0.434
aMann-Whitney U test; bPearson χ2 test; d, Cohen’s d. p-values <0.05 are shown in bold. MMSE, Mini Mental State Examination; CAMCOG,
Cambridge Cognitive Examination; CAMDEX, Cambridge Mental Disorders of the Elderly Examination; ADL, Activities of daily living; DAD,
Disability Assessment for Dementia; NPI, Neuropsychiatric Inventory; ZBI, Zarit Burden Inventory; SF-12, Short Form of Health Survey.
Table 2
Clinical data of participants
Baseline (1) 12 months (2) 24 months (3) 36 months (4) Within-subjects
(n = 119) (n = 119) (n = 119) (n = 119) F p η2p
QoL-AD (mean ± SD)
Patient 34.7 ± 4.6 35.2 ± 4.5 34.8 ± 4.8 35.1 ± 5.0 0.9 0.439 0.02
Caregiver 31.9 ± 5.0 32.7 ± 5.0 31.1 ± 5.3d 30.5 ± 4.9c,e 9.4 <0.001 0.19
Discrepancy QoL 2.8 ± 4.8 2.4 ± 4.9 3.6 ± 6.0 4.6 ± 6.0c,e 6.4 <0.001 0.14
Patient factors (mean ± SD)
MMSE (cognition) 18.9 ± 3.6 18.5 ± 3.4 18.3 ± 4.7 15.3 ± 5.2c,e,f 37.9 <0.001 0.49
CAMCOG (cognition) 58.9 ± 9.9 56.5 ± 11.2a 53.4 ± 12.9b,d 48.6 ± 16.7c,e,f 24.5 <0.001 0.38
DAD (function) 69.8 ± 7.7 66.9 ± 9.5a 63.3 ± 9.9b,d 59.1 ± 10.5c,e,f 52.5 <0.001 0.57
NPI (behavior) 9.4 ± 9.4 9.0 ± 12.3 10.4 ± 11.7 11.1 ± 11.2 1.1 0.341 0.02
Agitation 0.8 ± 1.8 0.6 ± 1.9 1.0 ± 2.5 1.2 ± 2.9 1.3 0.266 0.03
Depression 1.5 ± 2.8 1.0 ± 2.5 0.9 ± 2.2 0.7 ± 1.9c 2.6 0.051 0.06
Anxiety 0.7 ± 1.7 0.8 ± 2.2 0.5 ± 1.8 1.4 ± 2.8f 4.3 0.006 0.10
Apathy 2.2 ± 3.0 2.1 ± 3.3 2.9 ± 4.0 3.1 ± 3.9e 3.9 0.010 0.09
Aberrant motor 0.2 ± 1.1 0.3 ± 1.8 0.8 ± 2.4 0.7 ± 2.3 3.0 0.030 0.07
CAMDEX (n, %)
Depression, mild-mod. 17 (14.3) 12 (10.1) 16 (13.4) 20 (16.8) 2.0 0.569
Dementia, moderate 13 (10.9) 29 (24.4) 45 (37.8) 66 (55.5) 40.2 <0.001
Anosognosia 11 (9.2) 16 (13.4) 23 (19.3) 32 (26.9) 12.1 0.006
Caregiver factors (mean ± SD)
ZBI (burden) 39.7 ± 12.4 40.3 ± 11.5 42.7 ± 13.9b,d 43.5 ± 13.6c,e 5.6 0.001 0.12
SF-12 (physical health) 49.9 ± 9.2 49.6 ± 9.1 49.2 ± 9.4) 49.1 ± 9.3 0.3 0.771 0.01
SF-12 (mental health) 46.7 ± 11.0 45.9 ± 11.0 45.2 ± 10.8 45.7 ± 11.3 0.5 0.656 0.01
F, ANOVA, repeated measures (df = 3,116); η2p , partial eta squared; Pearson χ2 test (df = 3) for categorical variables. Significant with Bonferroni
post-hoc, Contrasts = a1-2, b1-3, c1-4, d2-3, e2-4, f 3-4. p-values <0.05 are shown in bold. QoL-AD, Quality of Life-Alzheimer’s Disease scale;
MMSE, Mini Mental State Examination; CAMCOG, Cambridge Cognitive Examination; CAMDEX, Cambridge Mental Disorders of the Elderly
Examination; DAD, Disability Assessment for Dementia; NPI, Neuropsychiatric Inventory; ZBI, Zarit Burden Inventory; SF-12, Short Form of
Health Survey.
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Table 3
Socio-demographic data and quality of life of patients
n Baseline (1) 12 months (2) 24 months (3) 36 months (4) Differences
(n = 119) (n = 119) (n = 119) (n = 119) F p η2p
QoL-AD patient
Gender
Men 43 36.1 ± 4.8 36.5 ± 4.3 35.9 ± 5.7 35.8 ± 5.3 W 0.5 0.627 0.01
Women 76 33.9 ± 4.3 34.5 ± 4.6 34.2 ± 4.2 34.7 ± 4.8 W 0.8 0.444 0.01
z (p) 2.2 (0.022) 2.3 (0.018) 1.8 (0.061) 1.0 (0.316) B 5.2 0.023 0.04
Schooling
<6 years 47 35.0 ± 4.7 35.5 ± 4.5 34.8 ± 4.5 35.5 ± 5.0 W 0.6 0.616 0.01
6–8 years 56 34.2 ± 4.6 34.4 ± 4.5 34.3 ± 5.1 34.0 ± 4.8 W 0.2 0.845 0.00
>8 years 16 35.8 ± 4.6 37.2 ± 4.3 36.8 ± 4.7 38.1 ± 4.5 W 1.3 0.276 0.08
χ2 (p) 2.9 (0.232) 4.7 (0.092) 4.3 (0.115) 9.3 (0.009) B 3.1 0.048 0.05
QoL-AD caregivers
Gender
Men 37 31.3 ± 5.1 32.0 ± 5.1 30.9 ± 5.3 30.2 ± 6.2 W 1.9 0.131 0.05
Women 82 32.1 ± 4.9 33.1 ± 4.9 31.2 ± 5.3d 30.7 ± 4.3e W 8.0 <0.001 0.09
t (p) 0.8 (0.413) 1.0 (0.299) 0.3 (0.762) 0.5 (0.605) B 0.6 0.419 0.00
Schooling
<6 years 24 31.1 ± 4.5 32.6 ± 4.3 30.6 ± 6.3 29.9 ± 6.6 W 1.6 0.189 0.06
6–8 years 34 32.3 ± 5.3 32.1 ± 5.0 31.7 ± 5.0 30.2 ± 4.6e W 3.5 0.017 0.09
>8 years 61 32.0 ± 5.0 33.2 ± 5.2 31.1 ± 5.1d 30.9 ± 4.4e W 6.6 <0.001 0.10
F (p) 0.4 (0.658) 0.5 (0.585) 0.3 (0.716) 0.4 (0.627) B 0.2 0.764 0.00
Relationship
Husband 22 31.8 ± 4.8 33.5 ± 3.8 32.8 ± 4.8 32.1 ± 6.3 W 1.1 0.338 0.05
Daughter 40 32.3 ± 4.5 33.1 ± 4.7 32.0 ± 5.0 31.8 ± 3.9 W 1.5 0.218 0.03
Wife 33 32.7 ± 5.1 32.9 ± 5.6 29.9 ± 5.7d 29.4 ± 4.5c,e W 8.2 <0.001 0.20
Son 15 30.6 ± 5.8 29.9 ± 6.2 28.2 ± 5.0 27.3 ± 5.1 W 2.8 0.048 0.17
F (p) 0.6 (0.576) 1.7 (0.165) 3.2 (0.025) 4.5 (0.005) B 2.7 0.046 0.07
F, ANOVA; η2p , partial eta squared; z, Mann-Whitney U test; χ2, Chi-squared test; t, Student’s t test. p-values <0.05 are shown in bold. B,
Between-subjects; W, Within-subjects. Significant with Bonferroni post-hoc, Contrasts = a1-2, b1-3, c1-4, d 2-3, e 2-4, f 3-4. QoL-AD, Quality
of Life-Alzheimer’s Disease scale.
Socio-demographic data and perceived QoL
In the repeated measures (between-subjects) anal-
ysis of patient data, the most important differences
were related to two factors: gender, with men giv-
ing higher ratings than women of their own QoL
(F1,117 = 5.2, p = 0.023, η2p = 0.04), and level of edu-
cation, with higher ratings of QoL being given by
the more educated patients (F2,116 = 3.1, p = 0.048,
η2p = 0.05). No significant differences were observed
as regards the relationship to the caregiver, the patient’s
age, or whether or not patient and caregiver lived
together.
In the repeated measures (between subjects) analysis
of caregiver data, the most important difference con-
cerned the relationship between patient and caregiver,
with wives and sons giving lower ratings of QoL-p than
did husbands and daughters (F3,106 = 2.7, p = 0.046,
η2p = 0.07). Although there were no overall differences
related to gender, female caregivers showed a greater
decline in their scores over the three-year follow-up
period. The same trend was observed among caregivers
with the highest level of education, whose ratings of
QoL-p also showed the greatest decline over the three
years. No significant differences were observed in rela-
tion to the caregiver’s age or whether or not patient and
caregiver lived together. The complete data are shown
in Table 3.
Factors associated with changes in patient and
caregiver ratings of QoL-p
The multivariate linear regression analysis identified
the factors associated with perceived QoL-p at base-
line and 36 months later, as well as the changes that
occurred during the follow-up period (Table 4).
Patients
At baseline the factors associated with a better per-
ceived quality of life were less depression, male gender,
and less apathy. In the final assessment, male gender
and, especially, less depression continued to be associ-
ated with a more positive view of QoL-p, although at 36
months the following factors also showed an associa-
tion: higher functional status, greater disinhibition, and
greater anosognosia. The differences between baseline
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Table 5
(Cut-off) Baseline 12 months 24 months 36 months Patients-caregivers
n Mean ± SD Mean ± SD Mean ± SD Mean ± SD between-subjects
F p η2p
Patient factors
DAD. ADL (±65) 17.1 <0.001 0.12
Low disability 66 1.5 ± 4.3 1.0 ± 3.9 2.3 ± 5.5 3.1 ± 5.7
High disability 53 4.3 ± 5.1 4.3 ± 5.5 5.3 ± 6.3 6.4 ± 6.0
t(p) 3.2 (0.002) 3.7 (<0.001) 2.7 (0.008) 3.0 (0.003)
NPI. Apathy (±2.6) 15.4 <0.001 0.11
Low apathy 69 2.2 ± 4.9 1.0 ± 4.2 2.1 ± 5.7 3.2 ± 6.1
High apathy 50 3.6 ± 4.7 4.4 ± 5.2 5.7 ± 5.9 6.5 ± 5.3
t(p) 1.5 (0.117) 3.9 (<0.001) 3.3 (0.001) 3.0 (0.003)
NPI. Agitation (±0.9) 13.0 <0.001 0.10
Low agitation 79 1.8 ± 4.7 1.6 ± 4.9 2.6 ± 6.0 3.4 ± 5.7
High agitation 40 4.6 ± 4.7 4.0 ± 4.7 5.7 ± 5.5 6.8 ± 6.1
t(p) 3.0 (0.003) 2.4 (0.016) 2.6 (0.009) 2.9 (0.004)
Anosognosia 11.9 0.001 0.09
No 74 1.8 ± 4.6 1.5 ± 4.5 2.4 ± 5.7 2.7 ± 5.4
Yes 45 4.4 ± 4.8 4.0 ± 5.2 4.8 ± 5.8 7.6 ± 5.8
t(p) 2.8 (0.005) 2.7 (0.006) 2.2 (0.477) 4.5 (<0.001)
CAMCOG (±55) 0.6 0.427 0.00
Low decline 62 3.2 ± 4.6 2.0 ± 4.5 4.0 ± 5.7 2.9 ± 5.4
High decline 57 2.4 ± 5.1 2.8 ± 5.3 3.3 ± 6.3 6.1 ± 6.2
t(p) 0.8 (0.405) 0.9 (0.349) 0.6 (0.528) 2.8 (0.005)
Caregiver factors
ZBI. Burden (±42) 9.0 0.003 0.07
Low burden 68 1.8 ± 4.9 1.6 ± 4.7 2.2 ± 5.8 3.7 ± 6.0
High burden 51 4.1 ± 4.6 3.5 ± 5.1 5.5 ± 5.9 5.7 ± 5.8
t(p) 2.5 (0.013) 2.0 (0.043) 2.9 (0.004) 1.7 (0.083)
SF-12. Mental (±46) 10.1 0.002 0.08
Better health 72 1.7 ± 4.6 1.7 ± 4.4 2.6 ± 5.5 3.5 ± 5.8
Worse health 47 4.5 ± 4.8 3.6 ± 5.5 5.2 ± 6.5 6.2 ± 6.0
t(p) 3.1 (0.002) 2.0 (0.043) 2.2 (0.024) 2.3 (0.018)
Note: The values indicate the difference between the QoL-p ratings of patients and caregivers at each assessment point and in the sub-groups
(high vs. low scores) for each factor. The cut-off point is the mean of the four assessments for continuous variables. F, Repeated measures
(df = 1,117); η2p , partial eta squared; t, Student’s t test (df = 117). p-values <0.05 are shown in bold. CAMDEX (Anosognosia), Cambridge
Mental Disorders of the Elderly Examination; CAMCOG, Cambridge Cognitive Examination; NPI, Neuropsychiatric Inventory; DAD, Disability
Assessment for Dementia; ADL, Activities of daily living; ZBI, Zarit burden Inventory; SF-12, Short Form of Health Survey; QoL-AD, Quality
of Life-Alzheimer’s Disease scale.
and final scores on the QoL-AD were not significantly
associated with any factor.
Caregivers
At baseline the main factors associated with higher
ratings of QoL-p were better functional status in
the patient and less burden in the caregiver; other
associated patient factors were less depression, fewer
appetite/eating abnormalities, and male gender. In the
final assessment, better functional status in the patient
and less burden in the caregiver continued to be
relevant, with other associated patient factors being
less agitation, depression, and apathy. The decline
(baseline-final) in caregiver ratings of QoL-p was par-
ticularly related to lower functional status and greater
depression in the patient, as well as to greater caregiver
burden; other associated patient factors were greater
agitation and appetite/eating abnormalities.
Functional impairment (rs , Spearman coeffi-
cient = −0.48 to −0.55, p < 0.001) and neuropsychi-
atric symptoms (rs = 0.41 to 0.53, p < 0.001) showed a
high correlation with caregiver burden, which in turn
was correlated with a more negative view of QoL-p
among caregivers (r, Pearson correlation = −0.51 to
−0.67, p < 0.001) at the four assessment points.
Degree of agreement between patient and
caregiver scores on the QoL-AD
The degree of agreement (kappa index) between
patient and caregiver ratings of the patient’s qual-
ity of life was poor for most of the 13 items:
values for unweighted and weighted kappa were,
respectively, ≤0.21 and ≤0.25. The items with the
highest mean kappa value (unweighted/weighted) at
the four assessment points were Mood (k = 0.20/0.25)
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Fig. 1. Patient factors. Patient and caregiver scores on the QoL-AD in relation to the influence of the most relevant patient factors. F, ANOVA,
repeated measures (between-subjects); df (1, 117); η2p , partial eta squared; QoL-AD, Quality of Life-Alzheimer’s Disease scale; CAMDEX,
Cambridge Mental Disorders of the Elderly Examination; NPI, Neuropsychiatric Inventory; DAD, Disability Assessment for Dementia.
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Fig. 2. Caregiver factors. Patient and caregiver scores on the QoL-AD in relation to the influence of the most relevant caregiver factors. F,
ANOVA, repeated measures (between-subjects); df (1, 117); η2p , partial eta squared; QoL-AD, Quality of Life-Alzheimer’s Disease scale; ZBI,
Zarit burden Inventory; SF-12, Short Form of Health Survey.
and Marriage (k = 0.21/0.25), while the lowest means
corresponded to Living situation (k = 0.07/0.07) and
Memory (k = 0.09/0.10). The mean kappa index
decreased progressively in magnitude across the four
assessment points, this being the case for both
unweighted (k = 0.17/0.13/0.11/0.10) and weighted
values (k = 0.20/0.17/0.15/0.14).
Discrepancies between patient and caregiver
scores on the QoL-AD
There was a general discrepancy between patients
and caregivers in terms of their total score on the QoL-
AD (F1,236 = 40.8, p < 0.001; η2p = 0.14).
More specific discrepancies, related with the various
factors, were examined by means of a repeated mea-
sures (between-subjects) analysis of variance, in which
the dependent variable was the discrepancy between
patient and caregiver scores on the QoL-AD at the four
assessment points. The between-subjects groups were
formed by dichotomizing the factors as follows: for
continuous variables we took the mean score at each
assessment point, while for categorical variables we
used the characteristics of subjects (Table 5).
The most notable discrepancies (η2p > 0.06)
between patient and caregiver ratings were observed
in the presence of anosognosia, which was associated
with higher scores in the patient, and agitation,
apathy, and functional deficits, which were associated
with lower ratings among caregivers. A number of
caregiver factors were also significantly related to
lower ratings of QoL-p, namely greater burden and
poorer mental health.
Figure 1 shows patient and caregiver scores on the
QoL-AD in relation to the patient factors that were
shown to be relevant: anosognosia (CAMDEX), apathy
and agitation (NPI), and functional capacity (DAD).
Similarly, Fig. 2 shows patient and caregiver scores on
the QoL-AD in relation to the caregiver factors that
were shown to be relevant: burden (ZBI) and mental
health (SF-12). These figures also show the statisti-
cal test values for differences among both patients and
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caregivers, as well as the significance of any discrep-
ancies between patient and caregiver scores.
It should be noted that depression, whether in
the clinical assessment (CAMDEX) (F1,117 = 2.5,
p = 0.111, η2p = 0.02) or when measured by the
corresponding NPI subscale (F1,117 = 2.0, p = 0.159,
η2p = 0.01), was not associated with discrepancies
in perceived QoL-p. In both patients and caregivers,
depression in the patient had a negative effect on rat-
ings of QoL-p, both at baseline and at 36 months (see
regression analysis).
Anosognosia, cognition, and patient and caregiver
ratings of QoL-p
The presence of anosognosia was associated with
greater cognitive impairment after 12 months, as mea-
sured by both the CAMCOG (F1,117 = 10.7, p = 0.001,
η2p = 0.08) and the MMSE (F1,117 = 5.0, p = 0.026,
η2p = 0.04).
In terms of QoL-p, patients with anosognosia gave
higher ratings of their quality of life (F1,117 = 7.0,
p = 0.009, η2p = 0.05), especially after 12 months.
However, cognitive status, whether measured by the
CAMCOG (F1,117 = 0.0, p = 0.928, η2p = 0.00) or the
MMSE (F1,117 = 0.1, p = 0.675, η2p = 0.00), had no
overall effect on their QoL-p ratings. Only for the
MMSE was there a significant effect at baseline, where
higher ratings of QoL-p were given by patients with
better cognitive function (z = 2.4, p = 0.015, d = 0.036).
For caregivers, anosognosia had no significant effect
on their ratings of QoL-p (F1,117 = 0.7, p = 0.373,
η2p = 0.00). Although cognitive status, as mea-
sured by both the CAMCOG (F1,117 = 0.4, p = 0.493,
η2p = 0.00) and the MMSE (F1,117 = 2.4, p = 0.118,
η2p = 0.02), had no overall effect on their ratings of
QoL-p, there was a significant effect for CAMCOG
scores at 36 months (t117 = 2.3, p = 0.019, d = 0.047),
with lower ratings being given to patients with greater
cognitive impairment.
The data regarding the relationship between anosog-
nosia, cognition, and patient and caregiver ratings of
QoL-p can be consulted in Supplementary Table 1.
DISCUSSION
Mention should first be made of the high number of
cases lost to follow-up, this being a common feature of
longitudinal studies of patients with AD. The percent-
age of lost cases (64.7%) is similar to that reported in
other studies conducted over three years (69.1%) [14]
or two years (64.3%) [12], (60.8%) [13]. As in these
studies, the patients lost to follow-up tended to be older
and more impaired.
Patient and caregiver perceptions of the patient’s
quality of life
The first objective of this study was to determine
changes over time in patient and caregiver ratings
of QoL-p. The results show that patients’ ratings
remained generally stable over the follow-up period,
despite their deteriorating status. By contrast, caregiver
ratings showed a clear decline as the patient became
more impaired.
The second objective was to identify the factors
associated with perceived QoL-p. The results for
patients show that depression was associated with
lower ratings of QoL-p, a finding that is consistent
with previous cross-sectional [17, 28] and longitudi-
nal studies [8]. Conversely, greater anosognosia was
related to better perceived QoL-p [29–31]. Male gen-
der and a higher level of education were also associated
with higher ratings of QoL-p.
The perception of caregivers was heavily influenced
by the patient’s functional status, both at baseline and
during follow-up, while over time neuropsychiatric
symptoms (depression, apathy, and agitation) came
to have a greater effect. Functional deficits [11, 14]
and neuropsychiatric symptoms [10, 11] are the fac-
tors most often cited in previous research as having a
negative impact on caregiver ratings of QoL-p. In the
present results, it is also important to note the minimal
influence of cognitive status, which was only signif-
icant in relation to caregiver ratings at 36 months.
Caregiver burden remained a significant factor at all
times, although its negative effect was greater at base-
line, as was the case for poorer mental health.
These results highlight the considerable subjectiv-
ity associated with the concept of quality of life. In
the early stages of dementia the positive ratings of
patients can be understood in terms of psychologi-
cal mechanisms, the disability paradox (adaptation to
change) [32], or processes of “self-maintaining” and
“self-adjusting” [33]. The more negative ratings of
caregivers can be explained by the impact of the diag-
nosis and the functional and behavioral changes in the
patient, which would produce greater burden.
However, these concepts are not sufficient to explain
the results for perceived QoL-p in the advanced stages
of AD. Here, greater anosognosia in patients, related
to increased neurological deterioration, would lead
them to have an overly positive view of their qual-
ity of life, one that differs considerably from their
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actual status. At this point, the more negative rating of
caregivers is consistent with the patient’s deteriorating
state. Note, however, that the smaller effect of burden
on caregiver ratings of QoL-p at 36 months would be
related to their increased adaptation to the situation
[34].
Discrepancies between patient and caregiver
ratings of the patient’s quality of life
The third objective of this study was to identify any
discrepancies between patient and caregiver ratings of
QoL-p. Caregiver ratings were always more negative
than those of patients, a finding corroborated by various
studies [10, 11, 13, 14]. However, the present study
makes a novel contribution by analyzing the specific
factors that might explain the observed discrepancies.
The first discrepancy is associated with the presence
of neuropsychiatric symptoms, especially agitation
[35] and apathy [35, 36]. Caregiver ratings were lower
in the presence of these symptoms, most likely as a
result of the distress they produce. By contrast, there
was greater agreement in the presence of depression in
the patient, which had a negative effect on the ratings
of both patients [8, 11, 35–38] and caregivers [14, 35,
36]. The impact of depression in this regard has been
widely reported.
The second discrepancy relates to anosognosia and
its effect on perceived QoL-p. This aspect has not been
widely investigated, although two cross-sectional stud-
ies addressing this important topic have recently been
published [31, 39]. Greater anosognosia led patients
to have a more positive view of their quality of life,
despite their general deterioration. This lack of aware-
ness regarding their actual status suggests that their
perceptions correspond to a mental image of them-
selves prior to their deterioration [40].
The third discrepancy concerns the patient’s func-
tional status. Although functional deficits had a
negative effect on patients themselves, especially dur-
ing the first year of follow-up when they were more
aware of their condition, the greatest effect was on
caregivers, in whom the patient’s functional impair-
ment produced a negative view of QoL-p throughout
the follow-up period [5, 14, 35, 36, 41].
Finally, the fourth discrepancy relates to caregiver
burden. Higher levels of burden were associated with a
greater discrepancy between patient and caregiver rat-
ings of QoL-p [37]. The main correlates of caregiver
burden were the severity of neuropsychiatric symp-
toms, poorer functional status, and lower ratings of the
patient’s quality of life [42]. A high degree of anosog-
nosia has previously been associated with greater
burden [43]. Very high levels of caregiver burden could
lead to overly negative views of the patient’s status,
especially with regard to neuropsychiatric symptoms
and the patient’s quality of life [34, 44, 45].
In contrast to these discrepancies, depression in the
patient had a negative effect on the QoL-p ratings of
both patients and caregivers. These results are con-
sistent with previous studies of caregivers [14] and
patients [8, 17, 28].
Anosognosia, cognition, and patient and caregiver
ratings of QoL-p
A specific aspect to consider is the relationship
between anosognosia, cognitive status, and perceived
quality of life. The present findings confirm the results
of a previous cross-sectional study [30], with anosog-
nosia being associated with greater impairment among
patients with moderate dementia. More specifically,
anosognosia was associated with better perceived
QoL-p in patients with moderate dementia, whereas
cognition was only associated with higher ratings of
perceived QoL-p among those with mild dementia. In
conclusion, among patients: a) anosognosia was asso-
ciated with cognitive impairment; b) anosognosia was
associated with better perceived QoL-p in moderate
dementia, whereas cognitive status did not influence
the ratings of these patients; and c) anosognosia and
cognition act as independent variables in relation to
perceived quality of life. Among caregivers, anosog-
nosia did not influence their perceptions of QoL-p,
and cognitive impairment only had a negative effect
on QoL-p ratings at 36 months.
Limitations of study
One important limitation, associated with longitudi-
nal studies of patients with AD, is the loss to follow-up
of older patients and those with more advanced demen-
tia, although in many of these patients (with a MMSE
score <10), the quality of life scale would not have been
applicable. This loss of patients may have led to a slight
increase in QoL-p scores, both among caregivers and
patients themselves.
Although, in the global analysis, patients’ scores
on the QoL-AD remained stable over time there were
notable differences between individuals. However, for
reasons of space the present article has not discussed
the factors associated with the sub-groups of patients
whose scores showed a decline, stability, or improve-
ment during follow-up. This aspect will be analyzed in
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subsequent research. A further limitation is that while
the clinical assessment of anosognosia provides impor-
tant information, the data are limited by the lack of a
specific instrument for this purpose. This issue should
be resolved in future longitudinal studies. Finally, it
should be noted that certain variables (e.g., hours per
day spent on caring, resources available, time since
taking up caregiving role, or comorbidities) could not
be controlled due to a lack of data.
CONCLUSIONS
Patients’ ratings of their own quality of life remained
stable over the follow-up period. The factor that had
the most negative and consistent effect on their ratings
was depression. Caregiver ratings of the patient’s qual-
ity of life showed a significant decline over time, such
that the discrepancies between patient and caregiver
ratings increased over follow-up. These discrepancies
were related to greater anosognosia, agitation, apathy,
and functional impairment in the patient, and to bur-
den and worse mental health in the caregiver. All these
factors should be taken into account when quality-of-
life measures are used to evaluate the effectiveness of
therapeutic interventions for patients with AD.
There is obviously a need to find ways of improving
caregivers’ perceptions of the patient’s status so as to
help reduce the burden they experience, since stress in
the caregiver can impact negatively on the patient. Psy-
choeducational and therapeutic interventions aimed at
family caregivers may be one way of enabling them to
learn more about dementia, to improve their relation-
ship with the patient, and to help them cope with the
stress that is an inherent part of caring for someone
with AD [46–49].
The most important contributions of the present
longitudinal study are as follows: 1) It identifies the
variables related to the greatest discrepancies in patient
and caregiver ratings of QoL-p; 2) It confirms that
depression in the patient does not produce discrepan-
cies, since the ratings of both patients and caregivers
were negatively affected by this variable; and 3)
Anosognosia and cognition are shown to be indepen-
dent variables in relation to patients’ perceptions of
their quality of life.
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